-
The FDA has officially approved the first new crown drug, Redsyvir
Time of Update: 2020-11-05
veklury's approval is based on the results of three randomized controlled clinical trials that included patients hospitalized for the severity of COVID-19.
randomized, double-blind, placebo-controlled clinical trial conducted by the U.S. National Institute of Allergy and Infectious Diseases assessed the time it takes patients to recover from COVID-19 within 29 days of treatment.
-
Annals of Neurology: New research helps promote neuronal regeneration
Time of Update: 2020-08-29
20, 2020 /--- -- Researchers at the University of Alberta recently found a treatment that can increase nerve regeneration three to five times faster, promising better treatments for trauma surgery patients.
-
Mov disorder: revealing the molecular mechanism of inhibiting Parkinson's disease
Time of Update: 2020-02-16
February 16, 2020 / BIOON / -- according to a recent study, a promising molecule offers hope for new therapies that can prevent or delay Parkinson's disease Researchers at the University of Helsinki h
-
Cell Rep: insulin improves mosquito immune response to West Nile virus
Time of Update: 2019-11-16
November 16, 2019 / BIOON / -- recently, a study led by Washington State University provided a new solution to inhibit the spread of West Nile virus, Zika virus and dengue virus In a study published t
-
[countdown] the third China Pharmaceutical R & D Innovation Summit and 2018 top 100 list of China's pharmaceutical R & D strength
Time of Update: 2018-05-30
For more details, please click here In the past 40 years of reform and opening up, China's pharmaceutical industry has undergone tremendous changes From 7.28 billion sales in 1978 to 2.96 trillion by
